Clinical Trials Logo
  1. Home
  2. Healthy
  3. NCT04889014
  4. Details
NCT04889014 Clinical Trial

Efficacy of Personal Pharmacogenomic Testing as an Educational Tool in the Pharmacy Curriculum

Healthy Clinical Trial

Official title:
Efficacy of Personal Pharmacogenomic Testing as an Educational Tool in the Pharmacy Curriculum

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04889014
Other study ID # 1602413309
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 3, 2016
Est. completion date March 1, 2021

Study information
Verified date May 2021
Source University of Arizona
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the use of personal genomic educational testing (PGET) on student knowledge and clinical skills surrounding pharmacogenomic testing to ensure it is of educational benefit to our student population. Students will be provided the opportunity to opt-in to test their own pharmacogenomic panel while participating in the standard curriculum. Students will have the option of using their own reports or dummy reports during classroom activities. Our hypothesis is that those students who have their own pharmacogenomics tested will show better overall performance.

Recruitment information / eligibility
Status Completed
Enrollment 233
Est. completion date March 1, 2021
Est. primary completion date March 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Willingness to provide informed consent for participation in the study - Enrolled in 3rd year Doctor of Pharmacy course Exclusion Criteria: - Unwilling or unable to provide consent for participation

Study Design

Related Conditions & MeSH terms

Intervention

Genetic:
• Personal genomic educational testing (PGET)
PGET consisted of a panel of pharmacogenomic variants
• No personal genomic educational testing (NPGET)
Lack of pharmacogenomic testing

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
University of Arizona

Outcome
Type Measure Description Time frame Safety issue
Primary Change in Pharmacogenomics Knowledge Assessment Improvement in performance on a knowledge assessment including eleven questions 8-12 weeks
Secondary Change in Self Assessment Questionnaire Improvement in Likert Scale Responses for 27 questions (scale of 1[worst] to 6[best]) 8-12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1